PMC:7696151 / 48168-48415 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1397","span":{"begin":217,"end":225},"obj":"Species"},{"id":"1406","span":{"begin":107,"end":110},"obj":"Chemical"},{"id":"1425","span":{"begin":241,"end":246},"obj":"Disease"}],"attributes":[{"id":"A1397","pred":"tao:has_database_id","subj":"1397","obj":"Tax:9606"},{"id":"A1406","pred":"tao:has_database_id","subj":"1406","obj":"MESH:D006886"},{"id":"A1425","pred":"tao:has_database_id","subj":"1425","obj":"MESH:D008180"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Indeed, a 24-week randomized, double-blind placebo-controlled trial demonstrated that the discontinuing of HCQ treatment (100–400 mg/kg/day for at least six months) increased the risk of exacerbations by 2.5 times in patients with quiescent lupus."}

{"project":"LitCovid-sentences","denotations":[{"id":"T313","span":{"begin":0,"end":247},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Indeed, a 24-week randomized, double-blind placebo-controlled trial demonstrated that the discontinuing of HCQ treatment (100–400 mg/kg/day for at least six months) increased the risk of exacerbations by 2.5 times in patients with quiescent lupus."}